We are currently witnessing an evolution from the current nonspecific imaging methods toward patient- and disease-specific imaging evaluation based on morphologic, physiologic, molecular and genetic markers of disease.

This molecular imaging evolution is stimulated through the use of multi-modality imaging systems and "smart" specific imaging agents for achieving the key tasks of accurate diagnosis, treatment planning, treatment response prediction and evaluation, surveillance and prognosis.

In this workshop, we will explore and discuss the expanding role of imaging in translational and clinical research.